Duchenne MD Exon-skipping Therapy Is Now in Phase 1 Trial: "Wave Life Sciences has started a Phase 1 clinical trial of a treatment for a gene malfunction linked to the most common form of Duchenne muscular dystrophy."
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment